Corporate News 10-Apr-17
Ajanta Pharma intimates of successful inspection of its facility at Dahej
By USFDA
Ajanta Pharma announced that its formulations facility at Dahej was inspected by USFDA from 03 April to 07 April 2017. At the end of the inspection, no Form 483 was issued to the Company.
Previous News
Ajanta Pharma
( Results - Analysis 29-Jul-22 11:30 )
Ajanta Pharma
( Results - Analysis 01-Feb-24 11:01 )
Ajanta Pharma
( Results - Analysis 03-May-24 09:49 )
Ajanta Pharma standalone net profit declines 13.07% in the March 2023 quarter
( Results - Announcements 05-May-23 17:24 )
Ajanta Pharma slips after US FDA issues form 483 to Dahej facility
( Hot Pursuit - 12-Sep-22 11:59 )
Ajanta Pharma fixes record date for buyback of shares
( Market Beat - Reports 28-Dec-21 14:39 )
Ajanta Pharma announces board meeting date
( Corporate News - 07-Mar-23 09:37 )
Ajanta Pharma's Dahej unit undergoes USFDA audit
( Corporate News - 12-Sep-22 12:00 )
Ajanta Pharma fixes record date for interim dividend
( Market Beat - Reports 22-Oct-21 09:16 )
Ajanta Pharma Ltd leads losers in 'A' group
( Hot Pursuit - 04-Nov-22 15:00 )
Ajanta Pharma consolidated net profit rises 45.30% in the March 2020 quarter
( Results - Announcements 20-May-20 16:50 )
Other Stories
Gujarat Inject (Kerala) declare Quarterly Result
07-Oct-24 17:27
eMudhra to table results
07-Oct-24 17:27
Morarka Finance declare Quarterly Result
07-Oct-24 17:26
Board of India Infrastructure Trust recommends final dividend
07-Oct-24 17:26
Dhanlaxmi Bank to hold board meeting
07-Oct-24 17:26
MIC Electronics to hold board meeting
07-Oct-24 17:26
LTIMindtree declare Quarterly Result
07-Oct-24 17:26
Kesar Petroproducts to conduct board meeting
07-Oct-24 17:25
Bharat Electronics declare Quarterly Result
07-Oct-24 17:25
Daulat Securities to conduct board meeting
07-Oct-24 17:25
Back
Top
